rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Wayde D. McMillan

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Solventum; Director, Hologic; EVP, CFO, Insulet.

In numbers

Trades disclosed
67
Buys
0
Sells
5
Bought
$0
Sold
$2.1M
Companies
3
Companies where not an officer
1
First trade
1 Mar 2019
Last trade
13 May 2026
Last filed
15 May 2026

Companies traded

Where they are an officer
SOLV SolventumOfficer · Medical Devices · last 13 May 20260 buys · 0 sells
PODD InsuletOfficer · Medical Devices · last 3 Jul 20230 buys · 5 sells
Everywhere else they filed: board seats, 10% stakes, other companies
HologicDirector · Medical Devices · last 7 Apr 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
13 May 2026filed 15 May 2026SOLV SolventumMedical DevicesSEC FORM 4 Code M—9,503 at $0.00filing
13 May 2026filed 15 May 2026SOLV SolventumMedical DevicesSEC FORM 4 Code F$328K4,404 at $74.41filing
13 May 2026filed 15 May 2026SOLV Solventumoption or derivative · Medical DevicesSEC FORM 4 Code M—9,503 at $0.00filing
13 May 2026filed 15 May 2026SOLV Solventumoption or derivative · Medical DevicesSEC FORM 4 Code M—9,503 at $0.00filing
13 May 2026filed 15 May 2026SOLV SolventumMedical DevicesSEC FORM 4 Code M—9,503 at $0.00filing
13 May 2026filed 15 May 2026SOLV SolventumMedical DevicesSEC FORM 4 Code F$328K4,404 at $74.41filing
7 Apr 2026filed 9 Apr 2026HologicMedical DevicesSEC FORM 4 Code D—4,932filing
7 Apr 2026filed 9 Apr 2026Hologicoption or derivative · Medical DevicesSEC FORM 4 Code D—5,171filing
7 Apr 2026filed 9 Apr 2026Hologicoption or derivativeSEC FORM 4 Code D—5,171filing
7 Apr 2026filed 9 Apr 2026HologicSEC FORM 4 Code D—4,932filing
6 Mar 2026filed 9 Mar 2026SOLV SolventumMedical DevicesSEC FORM 4 Code M—8,802 at $0.00filing
6 Mar 2026filed 9 Mar 2026SOLV SolventumMedical DevicesSEC FORM 4 Code F$193K2,786 at $69.41filing
6 Mar 2026filed 9 Mar 2026SOLV Solventumoption or derivative · Medical DevicesSEC FORM 4 Code M—8,802 at $0.00filing
6 Mar 2026filed 9 Mar 2026SOLV Solventumoption or derivative · Medical DevicesSEC FORM 4 Code M—8,802 at $0.00filing
6 Mar 2026filed 9 Mar 2026SOLV SolventumMedical DevicesSEC FORM 4 Code M—8,802 at $0.00filing
6 Mar 2026filed 9 Mar 2026SOLV SolventumMedical DevicesSEC FORM 4 Code F$193K2,786 at $69.41filing
5 Mar 2026filed 9 Mar 2026SOLV Solventumoption or derivative · Medical DevicesSEC FORM 4 Code A—35,321 at $0.00filing
5 Mar 2026filed 9 Mar 2026SOLV Solventumoption or derivative · Medical DevicesSEC FORM 4 Code A—35,321 at $0.00filing
26 Feb 2026filed 2 Mar 2026HologicMedical DevicesSEC FORM 4 Code A—3,190filing
26 Feb 2026filed 2 Mar 2026HologicSEC FORM 4 Code A—3,190filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care5

Buys in green, sells in red, by the company’s sector.

Related people

Flavia PeaseEVP & CFO · EVP & CFO at Insulet, filing Form 4 there in the last year
Robert Luther HuffinesDirector · Director at Insulet, filing Form 4 there in the last year
Jonathan Jay MazelskyDirector · Director at Insulet, filing Form 4 there in the last year
Bryan C. HansonChief Executive Officer · Chief Executive Officer at Solventum, filing Form 4 there in the last year
Ashley McEvoyDirector · President and CEO at Insulet, filing Form 4 there in the last year
Gilbert Ray Cisneros, Jr.Representative, CA-31 · Also traded PODD in the last 90 days
Donald J. TrumpPresident · Also traded PODD in the last 90 days